Pharma Mar Statistics

Total Valuation

Pharma Mar has a market cap or net worth of GBP 1.10 billion. The enterprise value is 1.03 billion.

Market Cap	1.10B
Enterprise Value	1.03B

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	Jun 25, 2025

Share Statistics

Current Share Class	17.57M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.74M

Valuation Ratios

The trailing PE ratio is 66.23 and the forward PE ratio is 21.82.

PE Ratio	66.23
Forward PE	21.82
PS Ratio	7.49
PB Ratio	6.67
P/TBV Ratio	6.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 87.44, with an EV/FCF ratio of -68.92.

EV / Earnings	61.70
EV / Sales	6.89
EV / EBITDA	87.44
EV / EBIT	157.61
EV / FCF	-68.92

Financial Position

The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.26.

Current Ratio	2.97
Quick Ratio	2.23
Debt / Equity	0.26
Debt / EBITDA	3.75
Debt / FCF	-2.92
Interest Coverage	2.34

Financial Efficiency

Return on equity (ROE) is 10.19% and return on invested capital (ROIC) is 1.99%.

Return on Equity (ROE)	10.19%
Return on Assets (ROA)	1.44%
Return on Invested Capital (ROIC)	1.99%
Return on Capital Employed (ROCE)	3.02%
Revenue Per Employee	294,048
Profits Per Employee	33,255
Employee Count	500
Asset Turnover	0.53
Inventory Turnover	0.21

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +134.59% in the last 52 weeks. The beta is -0.06, so Pharma Mar's price volatility has been lower than the market average.

Beta (5Y)	-0.06
52-Week Price Change	+134.59%
50-Day Moving Average	82.83
200-Day Moving Average	70.12
Relative Strength Index (RSI)	42.38
Average Volume (20 Days)	718

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharma Mar had revenue of GBP 147.02 million and earned 16.63 million in profits.

Revenue	147.02M
Gross Profit	138.81M
Operating Income	6.43M
Pretax Income	9.08M
Net Income	16.63M
EBITDA	9.81M
EBIT	6.43M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 117.83 million in cash and 43.45 million in debt, giving a net cash position of 74.38 million.

Cash & Cash Equivalents	117.83M
Total Debt	43.45M
Net Cash	74.38M
Net Cash Per Share	n/a
Equity (Book Value)	165.20M
Book Value Per Share	n/a
Working Capital	130.94M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.00 million and capital expenditures -6.89 million, giving a free cash flow of -14.88 million.

Operating Cash Flow	-8.00M
Capital Expenditures	-6.89M
Free Cash Flow	-14.88M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 94.41%, with operating and profit margins of 4.37% and 11.31%.

Gross Margin	94.41%
Operating Margin	4.37%
Pretax Margin	6.17%
Profit Margin	11.31%
EBITDA Margin	6.67%
EBIT Margin	4.37%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.55, which amounts to a dividend yield of 0.74%.

Dividend Per Share	0.55
Dividend Yield	0.74%
Dividend Growth (YoY)	21.36%
Years of Dividend Growth	5
Payout Ratio	57.46%
Buyback Yield	n/a
Shareholder Yield	0.74%
Earnings Yield	1.51%
FCF Yield	-1.35%

Dividend Details

Stock Splits

The last stock split was on July 22, 2020. It was a reverse split with a ratio of 0.0833333333.

Last Split Date	Jul 22, 2020
Split Type	Reverse
Split Ratio	0.0833333333

Scores

Pharma Mar has an Altman Z-Score of 6.33.

Altman Z-Score	6.33
Piotroski F-Score	n/a